Profil
Olaf Randerath is currently the Head-Medical Affairs at APONTIS PHARMA AG.
Prior to this, he worked as the Head-Development Projects at UCB Pharma GmbH and as the Head-Clinical Development at Schwarz Pharma Deutschland GmbH.
Aktive Positionen von Olaf Randerath
| Unternehmen | Position | Beginn |
|---|---|---|
| APONTIS PHARMA AG | Chief Tech/Sci/R&D Officer | - |
Ehemalige bekannte Positionen von Olaf Randerath
| Unternehmen | Position | Ende |
|---|---|---|
| Schwarz Pharma Deutschland GmbH | Corporate Officer/Principal | - |
UCB Pharma GmbH
 UCB Pharma GmbH Pharmaceuticals: MajorHealth Technology UCB Pharma GmbH manufactures and develops drugs. It manufactures prescription and non-prescription drugs. With its partners, the company engages in biopharmaceutical research and development. Apart from providing medication, the company provides support to the patients. The company was founded in 1928 and is headquartered in Monheim, Germany. | Corporate Officer/Principal | - |
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Börsennotierte Unternehmen | 1 |
|---|---|
| APONTIS PHARMA AG | Health Technology |
| Private Unternehmen | 2 |
|---|---|
UCB Pharma GmbH
UCB Pharma GmbH Pharmaceuticals: MajorHealth Technology UCB Pharma GmbH manufactures and develops drugs. It manufactures prescription and non-prescription drugs. With its partners, the company engages in biopharmaceutical research and development. Apart from providing medication, the company provides support to the patients. The company was founded in 1928 and is headquartered in Monheim, Germany. | Health Technology |
| Schwarz Pharma Deutschland GmbH |
